Log in
TSE:APHA

Aphria Inc. (APHA.TO) Stock Forecast, Price & News

C$5.97
-0.16 (-2.61 %)
(As of 10/23/2020 12:00 AM ET)
Add
Compare
Today's Range
C$5.97
Now: C$5.97▼
C$6.16
50-Day Range
C$5.62
MA: C$6.24▼
C$8.00
52-Week Range
C$2.65
Now: C$5.97▼
C$8.29
Volume2.36 million shs
Average Volume3.25 million shs
Market CapitalizationC$1.73 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Read More
Aphria Inc. (APHA.TO) logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.4Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.33 out of 5 stars

Industry, Sector and Symbol

Stock Exchange TSE
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolTSE:APHA
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.aphria.com
Phone844-427-4742
Employees1,200

Debt

Debt-to-Equity Ratio22.95
Current Ratio5.37
Quick Ratio3.02

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E Ratio97.57
P/E GrowthN/A

Sales & Book Value

Annual SalesC$560.92 million
Price / Sales3.08
Cash FlowC$1.34 per share
Price / Cash Flow4.47
Book ValueC$6.26 per share
Price / Book0.95

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares289,341,000
Market CapC$1.73 billion
Next Earnings Date1/12/2021 (Estimated)
OptionableOptionable
C$5.97
-0.16 (-2.61 %)
(As of 10/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive APHA News and Ratings via Email

Sign-up to receive the latest news and ratings for APHA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Aphria Inc. (APHA.TO) (TSE:APHA) Frequently Asked Questions

How has Aphria Inc. (APHA.TO)'s stock price been impacted by COVID-19?

Aphria Inc. (APHA.TO)'s stock was trading at C$3.68 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, APHA shares have increased by 62.2% and is now trading at C$5.97.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Aphria Inc. (APHA.TO)?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aphria Inc. (APHA.TO) in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Aphria Inc. (APHA.TO).

When is Aphria Inc. (APHA.TO)'s next earnings date?

Aphria Inc. (APHA.TO) is scheduled to release its next quarterly earnings announcement on Tuesday, January 12th 2021.
View our earnings forecast for Aphria Inc. (APHA.TO).

What price target have analysts set for APHA?

5 brokers have issued 12 month price objectives for Aphria Inc. (APHA.TO)'s shares. Their forecasts range from C$6.50 to C$11.00. On average, they expect Aphria Inc. (APHA.TO)'s stock price to reach C$8.52 in the next year. This suggests a possible upside of 42.7% from the stock's current price.
View analysts' price targets for Aphria Inc. (APHA.TO).

Who are some of Aphria Inc. (APHA.TO)'s key competitors?

Some companies that are related to Aphria Inc. (APHA.TO) include Hikma Pharmaceuticals PLC (HIK.L) (HIK), Evotec (EVT), Knight Therapeutics Inc. (GUD.TO) (GUD), Aurora Cannabis (ACB), HLS Therapeutics (HLS), Hexo (HEXO), HEXO (HEXO), Amryt Pharma plc (AMYT.L) (AMYT), OrganiGram (OGI), Benchmark (BMK), ICC Labs (ICC), Shield Therapeutics (STX), ESSA Pharma Inc. (EPI.V) (EPI), cbdMD (YCBD) and WeedMD Inc. (WMD.V) (WMD).
View all competitors.

What other stocks do shareholders of Aphria Inc. (APHA.TO) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aphria Inc. (APHA.TO) investors own include Aurora Cannabis (ACB), Canopy Growth (WEED), Canopy Growth (CGC), Aurora Cannabis (ACB), OrganiGram (OGI), KushCo (KSHB), NVIDIA (NVDA), CannTrust (CTST), Cronos Group (CRON) and Cronos Group (CRON).

Who are Aphria Inc. (APHA.TO)'s key executives?

Aphria Inc. (APHA.TO)'s management team includes the following people:
  • Mr. Irwin D. Simon, CEO & Chairman (Age 61, Pay $722.2k)
  • Mr. Carl A. Merton, Chief Financial Officer
  • Dr. Christelle Gedeon L.L.B., Ph.D., Chief Legal Officer
  • Mr. Victor Neufeld, Special Advisor (Age 66, Pay $444.71k)
  • Mr. Cole Cacciavillani, Special Advisor (Age 65, Pay $179.96k)

What is Aphria Inc. (APHA.TO)'s stock symbol?

Aphria Inc. (APHA.TO) trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APHA."

How do I buy shares of Aphria Inc. (APHA.TO)?

Shares of APHA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Aphria Inc. (APHA.TO)'s stock price today?

One share of APHA stock can currently be purchased for approximately C$5.97.

How big of a company is Aphria Inc. (APHA.TO)?

Aphria Inc. (APHA.TO) has a market capitalization of C$1.73 billion and generates C$560.92 million in revenue each year. Aphria Inc. (APHA.TO) employs 1,200 workers across the globe.

What is Aphria Inc. (APHA.TO)'s official website?

The official website for Aphria Inc. (APHA.TO) is www.aphria.com.

How can I contact Aphria Inc. (APHA.TO)?

Aphria Inc. (APHA.TO)'s mailing address is 245 Talbot St W Suite 103, LEAMINGTON, ON N8H 1N8, Canada. The company can be reached via phone at 844-427-4742.

This page was last updated on 10/24/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.